AGIO profile · all as-reported value updates
AGIOS PHARMACEUTICALS, INC. (AGIO) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating income | 2019 | -426,333,000 | -316,269,000 | 110,064,000 | +25.82% | revised comparative figure | 0001439222-20-000014 0001439222-22-000024 | 3 filed observations examined for this concept and period. |
| Operating income | 2020 | -316,149,000 | -335,916,000 | -19,767,000 | -5.88% | revised comparative figure | 0001439222-21-000029 0001439222-23-000039 | 3 filed observations examined for this concept and period. |